← Eichor
Study identifier: NCT07361302 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

Condition: Acute Ischemic Stroke  ·  Sponsor: Boehringer Ingelheim

PhasePhase 3
Planned participants1325
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is open to adults who had an acute stroke caused by a clot blocking a blood vessel in the brain (acute ischemic stroke). This study is for people who had an acute stroke or woke up with a stroke and were last seen well more than 4.5 hours before joining the study. Participants need to have imaging that shows there is brain tissue that can still be saved. They also should not be planned to receive a procedure to remove the blood clot. The purpose of this study is to find out whether a medicine called tenecteplase helps people recover from an acute stroke. Tenecteplase is already used to treat people within 4.5 hours after they had a stroke. This study tests if tenecteplase also helps if it is given more than 4.5 hours after the stroke. Participants are put into 2 groups randomly, which means by chance. One group gets tenecteplase as a single injection into a vein. The other group receives standard medical practice. Participants have an equal chance of receiving tenecteplase or the standard treatment. Participants are in the study for about 3 months. In the beginning, participants stay in the hospital for about 1 week. During the study, participants have 7 clinical examinations or visits. The last 2 of these visits will likely be done from home, allowing participants to complete certain assessments remotely. Doctors regularly test participants' recovery using a scale that measures the level of disability or dependence in daily activities. The results are compared …

This description comes directly from the study's public registry record.

Talk to the study team

Boehringer Ingelheim  ·  1-800-243-0127  ·  clintriage.rdg@boehringer-ingelheim.com

Always discuss trial participation with your own doctor first.

Locations (246)

Sanatorio GüemesBuenos Aires, ArgentinaNot Yet Recruiting
Hospital Italiano de Buenos AiresCiudad Autonoma Buenos Aires, ArgentinaNot Yet Recruiting
CEMICCiudad Autonoma Buenos Aires, ArgentinaNot Yet Recruiting
Hospital General de Agudos Dr. J. M. Ramos MejiaCiudad Autonoma Buenos Aires, ArgentinaNot Yet Recruiting
Clínica La Sagrada FamiliaCiudad Autonoma Buenos Aires, ArgentinaNot Yet Recruiting
Fundacion para la Lucha contra las Enfermedades Neurologicas de la Infancia - FLENICiudad Autonoma Buenos Aires, ArgentinaNot Yet Recruiting
Complejo Medico de la Policia Federal Argentina Churruca ViscaCiudad Autonoma Buenos Aires, ArgentinaNot Yet Recruiting
Clinica Privada Velez SarfieldCórdoba, ArgentinaNot Yet Recruiting
Nuevo Hospital San RoqueCórdoba, ArgentinaNot Yet Recruiting
Sanatorio AllendeCórdoba, ArgentinaNot Yet Recruiting
Sanatorio Privado Duarte Quiros De Clinica Colombo SACórdoba, ArgentinaNot Yet Recruiting
Sanatorio de la CanadaCórdoba, ArgentinaNot Yet Recruiting

+ 234 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07361302